{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-10", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "submissions": [ { "submission_type": "SUPPL", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060522", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "6234", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021812s001LTR.pdf", "date": "20060524", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "15", "submission_status": "AP", "submission_status_date": "20200131", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "61764", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021812Orig1s015ltr.pdf", "date": "20200204", "type": "Letter" }, { "id": "61766", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021812s015lbl.pdf", "date": "20200204", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "11", "submission_status": "AP", "submission_status_date": "20150210", "submission_public_notes": "Label for Womens Rogaine", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "16410", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021812Orig1s011lbl.pdf", "date": "20150217", "type": "Label" }, { "id": "28638", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021812Orig1s011ltr.pdf", "date": "20150212", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "8", "submission_status": "AP", "submission_status_date": "20121130", "review_priority": "STANDARD", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)" }, { "submission_type": "SUPPL", "submission_number": "16", "submission_status": "AP", "submission_status_date": "20201229", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "65780", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021812Orig1s016ltr.pdf", "date": "20210426", "type": "Letter" }, { "id": "65837", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021812Orig1s016lbl.pdf", "date": "20210107", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "14", "submission_status": "AP", "submission_status_date": "20190611", "submission_public_notes": "Label for Womens Rogaine", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "59016", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021812Orig1s014ltr.pdf", "date": "20190612", "type": "Letter" }, { "id": "59096", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021812Orig1s014lbl.pdf", "date": "20190617", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "20", "submission_status": "AP", "submission_status_date": "20260114", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "84763", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/019501Orig1s036,020834Orig1s021,021812Orig1s020ltr.pdf", "date": "20260115", "type": "Letter" }, { "id": "84764", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/019501Orig1s036,020834Orig1s021,021812Orig1s020lbl.pdf", "date": "20260115", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "10", "submission_status": "AP", "submission_status_date": "20131213", "submission_public_notes": "Label for Mens Rogaine", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "28637", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021812Orig1s010ltr.pdf", "date": "20131217", "type": "Letter" }, { "id": "37688", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021812Orig1s010lbl.pdf", "date": "20140113", "type": "Label" } ] }, { "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20060120", "submission_public_notes": "Label for Men's Rogaine", "review_priority": "STANDARD", "submission_class_code": "TYPE 3", "submission_class_code_description": "Type 3 - New Dosage Form", "application_docs": [ { "id": "21825", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021812s000TOC.html", "date": "20080506", "type": "Review" }, { "id": "28636", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021812s000ltr.pdf", "date": "20060130", "type": "Letter" }, { "id": "37687", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021812s000LBL.pdf", "date": "20060127", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "9", "submission_status": "AP", "submission_status_date": "20140228", "submission_public_notes": "Label for Women's Rogaine", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "6235", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021812Orig1s009ltr.pdf", "date": "20140304", "type": "Letter" }, { "id": "16409", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021812Orig1s009lbl.pdf", "date": "20140327", "type": "Label" } ] } ], "application_number": "NDA021812", "sponsor_name": "KENVUE BRANDS", "openfda": { "application_number": [ "NDA021812" ], "brand_name": [ "WOMENS ROGAINE UNSCENTED", "MENS ROGAINE MINOXIDIL UNSCENTED FORMULA" ], "generic_name": [ "MINOXIDIL" ], "manufacturer_name": [ "Kenvue Brands LLC" ], "product_ndc": [ "69968-0030", "69968-0031" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "TOPICAL" ], "substance_name": [ "MINOXIDIL" ], "rxcui": [ "645146", "702354" ], "spl_id": [ "2160c309-2fc9-b8c7-e063-6294a90ae132", "2163626e-0033-3de8-e063-6294a90a9cfd" ], "spl_set_id": [ "4d328537-b7f5-43cc-9837-c5a0c6c390f8", "1b5e2860-6855-4a65-8bbc-e064172a1adf" ], "package_ndc": [ "69968-0030-1", "69968-0030-2", "69968-0030-3", "69968-0031-1", "69968-0031-3", "69968-0031-4" ], "nui": [ "N0000175379", "N0000175564" ], "pharm_class_pe": [ "Arteriolar Vasodilation [PE]" ], "pharm_class_epc": [ "Arteriolar Vasodilator [EPC]" ], "unii": [ "5965120SH1" ] }, "products": [ { "product_number": "001", "reference_drug": "Yes", "brand_name": "MEN'S ROGAINE", "active_ingredients": [ { "name": "MINOXIDIL", "strength": "5%" } ], "reference_standard": "Yes", "dosage_form": "AEROSOL, FOAM", "route": "TOPICAL", "marketing_status": "Over-the-counter" }, { "product_number": "002", "reference_drug": "Yes", "brand_name": "WOMEN'S ROGAINE", "active_ingredients": [ { "name": "MINOXIDIL", "strength": "5%" } ], "reference_standard": "Yes", "dosage_form": "AEROSOL, FOAM", "route": "TOPICAL", "marketing_status": "Over-the-counter" } ] } ] }